Found 416 hits.
|
580. |
Kovalkova, E.+, Fomina, D., Borzova, E., Maltseva, N., Chernov, A., Serdoteckova, S., Weller, K., and Maurer, M.: Сomorbid inducible urticaria is linked to non-autoimmune chronic spontaneous urticaria: CURE insights. J. Allergy Clin. Immunol. Pract. 2024: 12; 482-490. IF: TBD (IF 2023: 8.20) |
o.580
|
218. |
Akin, C., Siebenhaar, F., Wechsler, J. B., Youngblood, B. A., and Maurer, M.+: Detecting changes in mast cell numbers vs. activation in human disease: a roadblock for current biomarkers? J. Allergy Clin. Immunol. Pract. 2024: 12; 1727-1737. IF: TBD (IF 2023: 8.20) |
r.218
|
581. |
Türk, M., Kocatürk, E., Ertas, R., Ensina, L. F., Ferruci, S. M., Grattan, C., Vestergaard, C., Zuberbier, T., Maurer, M.+, and Giménez-Arnau, A. M.: A global perspective on stepping down chronic spontaneous urticaria treatment: results of the UCARE SDown-CSU study. Clin. Transl. Allergy 2024: 14; e12343. IF: TBD (IF 2023: 4.60) |
o.581
|
582. |
Demir, S.+, Eyice-Karabacak, D., Kocatürk, E., Ünal, D., Toprak, İ. D., Korkmaz, P., Aslan, A. F., İmren, I. G., Dikicier, B., Kahveci, N., Öztop, N., Kara, R. Ö., İşsever, H., Maurer, M., Weller, K., and Gelincik, A.: Monitoring recurrent angioedema: findings from the Turkish angioedea control test validation study. Clin. Transl. Allergy 2024: 14; e12342. IF: TBD (IF 2023: 4.60) |
o.582
|
583. |
Metz, M.+, Zeidler, C., Hawro, T., Pereira, M., Maurer, M., Bonnekoh, H., Krause, K., Pritchard, T., Kwatra, S. G., Ständer, S., and Weller, K.+: Development and validation of a patient-reported outcome measure to assess disease control in chronic prurigo. JAMA Dermatol. 2024: 160; 187-193. IF: TBD (IF 2023: 11.50) |
o.583
|
594. |
Siiskonen, H., Fok, J. S., Buscone, S., Castellano Pellicena, I, Uzunbajakava, N., Botchkareva, N., Maurer, M.+, and Scheffel, J.: Human skin mast cells express photoreceptors. J. Eur. Acad. Dermatol. Venereol. 2024: 38; 629-631. IF: TBD (IF 2023: 8.40) |
o.594
|
595. |
Conti, D. M.+, Backer, V., Beyer, K., Bjermer, L., Chaker, A., Dramburg, S., Gaga, M., Gappa, M., Gevaert, P., Hamelmann, E., Hellings, P. W., Jesenak, M., Kopp, M., Maurer, M., Podesta, M., Ryan, D., Scadding, G., Wüstenberg, E., Wahn, U., and Lau, S.: EUFOREUM Berlin 2023: optimizing care for type 2 inflammatory diseases from clinic to AI: a pediatric focus. Pediatr. Allergy Immunol. 2024: 35; e14183. IF: TBD (IF 2023: 4.30) |
o.594
|
596. |
Riedl, M. A.+, Farkas, H., Aygören-Pürsün, E., Psarros, F., Soteres, D. F., Staevska, M., Cancian, M., Hagin, D., Honda, D., Melamed, I., Savic, S., Stobiecki, M., Busse, P. J., Dias de Castro, E., Agmon-Levin, N., Gower, R., Kessel, A., Kurowski, M., Lleonart, R., Grivcheva Panovska, V., Wedner, H. J., Audhya, P., K., Hao, J., Iverson, M., Smith, M. D., Yea, C. M., Lumry, W. R., Zanichelli, A., Bernstein, J. A., Maurer, M., and Cohn, D. M., for the KONFIDENT investigators: Oral sebetralstat for on-demand treatment of hereditary angioedema attacks. New Engl. J. Med. 2024: 391; 32-43. IF: TBD (IF 2023: 96.20) |
o.596
|
598. |
Maurer, M.+, Casale, T. B., Saini, S. S., Ben-Shoshan, M., Giménez-Arnau, A. M., Bernstein, J. A., Yagami, A., Stjepanovic, A., Radin, A., Staudinger, H. W., Patel, N., Amin, N., Akinlade, B., Fan, C., Bauer, D., Yancopoulos, G. D., Patel, K., Mannent, L. P., and Laws, E.: Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials. J. Allergy Clin. Immunol. 2024: 154; 184-194. IF: TBD (IF 2023: 11.40) |
o.598
|
599. |
Mak, H. W. F., Lee, E., Wong, J. C. Y. Weller, K., Maurer, M., and Li, P. H.+: Validity, reliability, and sensitivity of change of the traditional Chinese urticaria control test (UCT) in Hong Kong. J. Allergy Clin. Immunol. Glob. 2024: 3; 100290. IF: N/A |
o.599